Metraipolis › archive › dc_737bf0fc8762
New therapies, new challenges: Cystic lung disease after cancer immunotherapy — Europe PMC PMID:41631188
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41631188
- DOI
- 10.1016/j.rmcr.2025.102356
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T02:59:52.351Z
- SHA-256 of the archived text
6f20a46b5bac85c7d638cead9fe4d6f50feb56ecdc22442bd760ab608aa0868d- Stable URL of this page
https://metraipolis.com/documento/dc_737bf0fc8762
How to cite
New therapies, new challenges: Cystic lung disease after cancer immunotherapy — Europe PMC PMID:41631188 — Europe PMC (en), https://europepmc.org/article/MED/41631188 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_737bf0fc8762 (Metraipolis archive dc_737bf0fc8762, sha256 6f20a46b5bac85c7d638cead9fe4d6f50feb56ecdc22442bd760ab608aa0868d)
BibTeX
@misc{dc737bf0fc8762,
title = {New therapies, new challenges: Cystic lung disease after cancer immunotherapy — Europe PMC PMID:41631188},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41631188},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_737bf0fc8762; sha256 6f20a46b5bac85c7d638cead9fe4d6f50feb56ecdc22442bd760ab608aa0868d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41631188. Agents can read the archived copy with the MCP tool read_document.